Company Filing History:
Years Active: 1976-1983
Title: The Innovations of Hilton B Levy
Introduction
Hilton B Levy is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of innovative complexes that enhance antiviral responses in hosts. With a total of 5 patents, his work has had a profound impact on medical research and treatment methodologies.
Latest Patents
Levy's latest patents include a low molecular weight complex of polyriboinosinic-polyribocytidylic acid. This nuclease-resistant hydrophilic complex combines polyriboinosinic-polyribocytidylic acid, poly-l-lysine, and carboxymethylcellulose. The complex is designed to induce the synthesis of antiviral levels of interferon in hosts while minimizing toxicity reactions typically associated with larger molecular weight complexes. Another significant patent involves a similar nuclease-resistant hydrophilic complex, which is effective when administered in a pharmacologically acceptable aqueous carrier, such as saline solution, to induce antiviral responses in both human and non-human primate hosts.
Career Highlights
Throughout his career, Levy has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Secretary of Health. His research has been pivotal in advancing our understanding of antiviral therapies and their applications.
Collaborations
Levy has collaborated with notable colleagues such as John L Gerin and Thomas C Merigan. These partnerships have contributed to the success and impact of his research in the field.
Conclusion
Hilton B Levy's innovative work in developing antiviral complexes showcases his dedication to advancing medical science. His contributions continue to influence the field and provide new avenues for research and treatment.